FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084648346> ?p ?o ?g. }

• W2084648346 endingPage "743" @default.
• W2084648346 startingPage "737" @default.
• W2084648346 abstract "Primary focal segmental glomerulosclerosis (FSGS) is a major cause of nephrotic syndrome and eventual end-stage renal disease. It is known to be due to an abnormality of the visceral epithelial cells (podocytes) of the glomerulus. The morphological hallmark of primary FSGS is diffuse effacement of podocyte foot processes. The etiology of the podocyte damage is not been clearly established. FSGS can also be a secondary process due to underlying conditions including obesity and heroin use. In the secondary processes, the mechanism appears to be a decreased ratio of podocytes to the glomerular filtration surface area. Familial forms of FSGS also exist due to alterations of several different podocyte proteins. Primary FSGS is an increasing cause of end-stage renal disease. Recurrence of severe FSGS in renal allograft recipients presents a major challenge to transplant physicians. The incidence of recurrence is generally accepted to be between 20% and 30%. Risk factors for and characteristics of recurrence include a rapid progression of the primary disease to end-stage renal failure, early onset of nephrotic range proteinuria after allografting, frequent loss of the allograft, a high frequency of recurrence in subsequent allografts, and children less than 15 years of age. Some investigators have identified a circulating factor called the FSGS factor that appears to be associated with recurrence after transplantation. This factor has been shown to be a protein between 30 and 50 kd molecular weight. Logically, the possibility of a circulating factor associated with recurrence of FSGS led investigators to treat patients with plasmapheresis. Several studies have been reported with varying success. The response of patients to plasmapheresis seems to be completely individual. Other studies have added cyclophosphamide and/or mycophenolate mofetil to the plasmapheresis protocol. Again success in these studies has been variable. However, because some patients show complete recovery with plasmapheresis, individuals who develop recurrent FSGS after transplantation usually are given a trial of plasmapheresis therapy." @default.
• W2084648346 created "2016-06-24" @default.
• W2084648346 creator A5055023665 @default.
• W2084648346 date "2007-04-01" @default.
• W2084648346 modified "2023-09-23" @default.
• W2084648346 title "Focal Segmental Glomerulosclerosis and Renal Transplantation" @default.
• W2084648346 cites W1960285963 @default.
• W2084648346 cites W1968108840 @default.
• W2084648346 cites W1968924429 @default.
• W2084648346 cites W1971498397 @default.
• W2084648346 cites W1972310654 @default.
• W2084648346 cites W1972852343 @default.
• W2084648346 cites W1975302167 @default.
• W2084648346 cites W1978104878 @default.
• W2084648346 cites W1993387604 @default.
• W2084648346 cites W2000637899 @default.
• W2084648346 cites W2006686833 @default.
• W2084648346 cites W2009381751 @default.
• W2084648346 cites W2012077989 @default.
• W2084648346 cites W2015749483 @default.
• W2084648346 cites W2017844423 @default.
• W2084648346 cites W2019744676 @default.
• W2084648346 cites W2019928912 @default.
• W2084648346 cites W2033688895 @default.
• W2084648346 cites W2039080756 @default.
• W2084648346 cites W2039170446 @default.
• W2084648346 cites W2042365668 @default.
• W2084648346 cites W2042604174 @default.
• W2084648346 cites W2047876945 @default.
• W2084648346 cites W2050721412 @default.
• W2084648346 cites W2054225562 @default.
• W2084648346 cites W2056788975 @default.
• W2084648346 cites W2057142373 @default.
• W2084648346 cites W2063068068 @default.
• W2084648346 cites W2063411993 @default.
• W2084648346 cites W2081756875 @default.
• W2084648346 cites W2083934623 @default.
• W2084648346 cites W2089391563 @default.
• W2084648346 cites W2091670611 @default.
• W2084648346 cites W2093282748 @default.
• W2084648346 cites W2103827478 @default.
• W2084648346 cites W2104254325 @default.
• W2084648346 cites W2110230080 @default.
• W2084648346 cites W2117119128 @default.
• W2084648346 cites W2118684725 @default.
• W2084648346 cites W2126226666 @default.
• W2084648346 cites W2126712474 @default.
• W2084648346 cites W2127383350 @default.
• W2084648346 cites W2132849873 @default.
• W2084648346 cites W2133272865 @default.
• W2084648346 cites W2135510331 @default.
• W2084648346 cites W2137130069 @default.
• W2084648346 cites W2140277420 @default.
• W2084648346 cites W2140706483 @default.
• W2084648346 cites W2148572488 @default.
• W2084648346 cites W2157230648 @default.
• W2084648346 cites W2158393830 @default.
• W2084648346 cites W2167051832 @default.
• W2084648346 cites W2169510669 @default.
• W2084648346 cites W2323753285 @default.
• W2084648346 cites W2336972928 @default.
• W2084648346 cites W2414340246 @default.
• W2084648346 cites W2416470141 @default.
• W2084648346 cites W4247051351 @default.
• W2084648346 cites W4249666249 @default.
• W2084648346 doi "https://doi.org/10.1016/j.transproceed.2007.02.010" @default.
• W2084648346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17445586" @default.
• W2084648346 hasPublicationYear "2007" @default.
• W2084648346 type Work @default.
• W2084648346 sameAs 2084648346 @default.
• W2084648346 citedByCount "35" @default.
• W2084648346 countsByYear W20846483462012 @default.
• W2084648346 countsByYear W20846483462013 @default.
• W2084648346 countsByYear W20846483462014 @default.
• W2084648346 countsByYear W20846483462015 @default.
• W2084648346 countsByYear W20846483462016 @default.
• W2084648346 countsByYear W20846483462018 @default.
• W2084648346 countsByYear W20846483462019 @default.
• W2084648346 countsByYear W20846483462020 @default.
• W2084648346 countsByYear W20846483462021 @default.
• W2084648346 countsByYear W20846483462022 @default.
• W2084648346 crossrefType "journal-article" @default.
• W2084648346 hasAuthorship W2084648346A5055023665 @default.
• W2084648346 hasConcept C126322002 @default.
• W2084648346 hasConcept C126894567 @default.
• W2084648346 hasConcept C142724271 @default.
• W2084648346 hasConcept C2777146197 @default.
• W2084648346 hasConcept C2777390665 @default.
• W2084648346 hasConcept C2778415529 @default.
• W2084648346 hasConcept C2778930706 @default.
• W2084648346 hasConcept C2779561371 @default.
• W2084648346 hasConcept C2780091579 @default.
• W2084648346 hasConcept C2911091166 @default.
• W2084648346 hasConcept C71924100 @default.
• W2084648346 hasConceptScore W2084648346C126322002 @default.
• W2084648346 hasConceptScore W2084648346C126894567 @default.
• W2084648346 hasConceptScore W2084648346C142724271 @default.
• W2084648346 hasConceptScore W2084648346C2777146197 @default.

• next